CollPlant Biotechnologies Ltd Research and Development Expense
CollPlant Biotechnologies Ltd (CLGN) reported Research and Development Expense of $8.19 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-26
- CollPlant Biotechnologies Ltd research and development expense for the quarter ending 2025-06-30 was $2.01M, a 25.36% decline year-over-year.
- CollPlant Biotechnologies Ltd research and development expense for the quarter ending 2024-06-30 was $2.70M, a 4.78% increase year-over-year.
- CollPlant Biotechnologies Ltd research and development expense for the quarter ending 2023-06-30 was $2.57M, a 0.96% decline year-over-year.
- CollPlant Biotechnologies Ltd research and development expense for the quarter ending 2022-06-30 was $2.60M, a 36.72% increase year-over-year.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $8.19M 20-F · filed 2026-03-26 | |||
| 2025-06-30 | $2.01M 6-K · filed 2025-08-20 | $4.12M 6-K · filed 2025-08-20 | ||
| 2024-12-31 | $10.52M 20-F · filed 2026-03-26 | |||
| 2024-06-30 | $2.70M 6-K · filed 2025-08-20 | $5.10M 6-K · filed 2025-08-20 | ||
| 2023-12-31 | $10.48M 20-F · filed 2026-03-26 | |||
| 2023-06-30 | $2.57M 6-K · filed 2024-08-20 | $4.68M 6-K · filed 2024-08-20 | ||
| 2022-12-31 | $10.26M 20-F · filed 2025-03-26 | |||
| 2022-06-30 | $2.60M 6-K · filed 2023-08-24 | $4.84M 6-K · filed 2023-08-24 | ||
| 2021-12-31 | $7.63M 20-F · filed 2024-04-04 | |||
| 2021-06-30 | $1.90M 6-K · filed 2022-08-25 | $3.53M 6-K · filed 2022-08-25 | ||
| 2020-12-31 | $4.07M 20-F · filed 2023-03-29 | |||
| 2020-06-30 | $1.00M 6-K · filed 2021-08-19 | $1.81M 6-K · filed 2021-08-19 | ||
| 2019-12-31 | $4.41M 20-F · filed 2022-03-24 | $28.00K 20-F · filed 2020-04-01 | ||
| 2019-06-30 | $1.08M 6-K · filed 2020-08-28 | $1.86M 6-K · filed 2020-08-28 | ||
| 2018-12-31 | $3.88M 20-F · filed 2021-03-26 | $327.00K 20-F · filed 2020-04-01 | ||
| 2017-12-31 | $584.00K 20-F · filed 2020-04-01 |